312
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Design and Fungicidal Activity of Mucoadhesive Lactoferrin Tablets for the Treatment of Oropharyngeal Candidosis

, , , , , , , & show all
Pages 31-38 | Published online: 29 Sep 2008

  • Armstrong, N. A. 1990. Considerations of compression speed in tablet manufacture. Pham. Technol. Int. 2:19-27.
  • Bouwstra, J. A., and Junginger, H. E. 1993. Hydrogels. In Encyclopedia of pharmaceutical technology, vol. 7, eds. J. Swarbrick and J. C. Boylan, 441-465, New York: Marcel Dekker Inc.
  • Colombo, P., Bettini, R., Massimo, G., Catellarni, P. L., Santi, P., and Peppas, N. A. 1995. Drug diffusion front movement is important in drug release control from swellable matrix tablets. J. Pharm. Sci. 84:991-997.
  • Danckwerts, M. P. 1994. Development of a zero-order release oral compressed tablet with potential for commercial tabletting production. Int. J. Pharm. 112:37-45.
  • Danckwerts, M. P., and Van der Watt, J. G. 1995. The effect of processing variables on the compression properties of controlled release core-in-cup compressed tablets from a new adjustable punch. Int. J. Pharm. 123:85-94.
  • Gao, P., Nixon, P. R., and Skoug, J. W. 1995. Diffusion in HPMC gels. II. Prediction of drug release rates from hydrophilic matrix extended-release dosage farms. Pharm. Res. 12:965-971.
  • Harmsen, M. C., Swart, P. J., de Béthune, M.-P., Pauwels, R., De Clercq, E., The, T. H., and Meijer, D. K. F. 1995. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J. Infect. Dis. 172:380-388.
  • Hokhodchi, A., and Rubinstein, M. H. 1996. Compaction simulators in tabletting research. Pharm. Technol. Eur. Yearbook 1996:6-67.
  • Ju, R. T. C., Nixon, P. R., and Patel, M. V. 1995a. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. J. Pharm. Sci. 84:1455-1463.
  • Ju, R. T. C., Nixon, P. R., Patel, M. V., and Tong, D. M. 1995b. Drug release from hydrophilic matrices. 2. A mathematical model based on the polymer disentanglement concentration and the diffusion layer. J. Pharm. Sci. 84:1464-1477.
  • Kamath, K. R., and Park, K. 1994. Mucosal adhesive preparations. In Encyclopedia of pharmaceutical technology, vol. 10, eds. J. Swarbrick and J. C. Boylan, 133-163, New York: Marcel Dekker Inc.
  • Kuipers, M. E., de Vries, H. G., Eikelboom, M. C., Meijer, D. K. R, and Swart, P. J. 1999. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimiciob. Agents Chemother. 43:2635-2641.
  • Kuipers, M. E., de Vries, H. G., Heegsma, J. H., Van den Berg, J. J. M., Meijer, D. K. F., and Swart, P. J. 2001. Conditions influencing the antifungal activity of lactoferrin and antifungal drugs against clinical isolates of Candida. Apmis, In press.
  • Lenander-Lumikari, M., and Johansson, I.1995. Effect of saliva composition on growth of Candida albicans and Torulopsis glabrata. Oral Microbiol. Immunol. 10:233-240.
  • Marchetti, M., Longhi, C., Conte, M. P., Pisani, S., Valenti, P., and Seganti, L. 1996. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res. 29:221 -231.
  • NCCLS. 1997. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A. Wayne, PA: National Committee for Clinical Laboratory Standards.
  • Nikawa, H., Samaranayake, L. P., Tenovuo, J., Pang, K. M., and Hamada, T. 1993. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei. Arch. Oral Biol. 38:1057-1063.
  • Oppenheim, F. G., Xu, T., McMillian, F. M., Levitz, S. M., Diamond, R. D., Offner, G. D., and Troxler, R. F. 1988. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J. Biol. Chem. 263:7472-7477.
  • Pfaller, M. A., Burmeister, L., Bartlett, M. S., and Rinaldi, M. G. 1988. MuIticenter evaluation of four methods of yeast inoculum preparation. J. Clin. Microbiol. 26:1437-1441.
  • Pham, A. T., and Lee, P. 1.1994. Probing the mechanisms of drug release from hydroxypropylmethyl-cellulos e matrices. Pharm. Res. 11:1379-1384.
  • Pollock, J. J., Denepitiya, L., Mackay, B. J., and lacona, V. J. 1984. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect. Immun. 44:702-707.
  • Samaranayake, L. P., and Ferguson, M. M. 1994. Delivery of antifungal agents to the oral cavity. Adv. Drug Del Rev. 13:161 -179.
  • Swart, P. J., Kuipers, M. E., Smit, C., van der Strate, B. W. A., Harmsen, M. C., and Meijer, D. K. R 1998. Lactoferrin. Antiviral activity of lactoferrin. Adv. Exp. Med. Biol. 443:205-213.
  • Tahara, K., Yamamoto, K., and Nishihata, T. 1995. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methyl-cellulose 2910. J. Cont. Release. 35:59-66.
  • Van der Voort Maarschalk, K., Vromans, H., Bolhuis, G. K., and Lerk, C. R 1998. Influence of plasticizers on tableting properties of polymers. Drug Dev. Ind. Pharm. 24:261-268.
  • Wakabayashi, H., Abe, S., Okutomi, T., Tansho, S., Kawase, K., and Yamaguchi, H. 1996. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol. Immunol. 40:821-825.
  • Wilson, C. G., and Washington, N. 1989. Physiological Pharmaceutics: Biological Barriers to Drug Absorption, 21-36, New York: Ellis Horwood Ltd., Chichester.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.